BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6398870)

  • 1. [Platinum complexes as potential antineoplastic drugs].
    Kuduk-Jaworska J
    Postepy Hig Med Dosw; 1984; 38(3):281-322. PubMed ID: 6398870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitumor activity of mixed carboxylate complexes of platinum (II) with ammonium and cycloalkylamines].
    Konovalova AL; Chel'tsov PA; Kravchenko AN; Shchelokov RN
    Dokl Akad Nauk SSSR; 1987; 294(3):726-30. PubMed ID: 3608773
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coordinated platinum compounds in experimental and clinical oncology].
    Lobanova EA; Kozlova MD; Singin AS; Serebriakov NG
    Med Radiol (Mosk); 1984 Jun; 29(6):59-63. PubMed ID: 6376996
    [No Abstract]   [Full Text] [Related]  

  • 4. Organo-platinum complexes as antitumor agents (review).
    Hill JM; Speer RJ
    Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of therapeutic doses of isotopically labeled platinum antitumor agents in the mouse and rat.
    Robins AB; Leach MO
    Cancer Treat Rep; 1983 Mar; 67(3):245-52. PubMed ID: 6682013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum coordination complexes in cancer chemotherapy.
    Rosenberg B
    Naturwissenschaften; 1973 Sep; 60(9):399-406. PubMed ID: 4203933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitumor activity of mixed cis-complexes of platinum(II) with ammonia and cycloalkylamines].
    Konovalova AL; Presnov MA; Chel'tsov PA; Kravchenko AN; Ivanov VB
    Dokl Akad Nauk SSSR; 1985; 281(1):200-3. PubMed ID: 4039648
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitumor effect of complex compounds of tetravalent platinum].
    Konovalova AL; Presnov MA; Zheligovskaia NN; Treshchalina EM
    Dokl Akad Nauk SSSR; 1977; 234(1):223-6. PubMed ID: 880861
    [No Abstract]   [Full Text] [Related]  

  • 9. Cisplatin and related anticancer drugs: recent advances and insights.
    Barnes KR; Lippard SJ
    Met Ions Biol Syst; 2004; 42():143-77. PubMed ID: 15206102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antineoplastic activity of complex compounds of platinum(IV)].
    Presnov MA; Zheligovskaia NN; Babkov AV; Konovalova AL; Budanova NS
    Dokl Akad Nauk SSSR; 1976 JUL-AUG; 229(1):226-9. PubMed ID: 954573
    [No Abstract]   [Full Text] [Related]  

  • 11. Whither carboplatin? A replacement for or an alternative to cisplatin?
    Gil A
    J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520
    [No Abstract]   [Full Text] [Related]  

  • 12. [Second generation of antitumor complex platinum compounds in experimental and clinical chemotherapy].
    Presnov MA; Konovalova AL; Gorbunova VA
    Vestn Akad Med Nauk SSSR; 1986; (12):79-89. PubMed ID: 3548147
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complex compounds of platinum in the chemotherapy of malignant tumors].
    Presnov MA; Konovalova AL; Korol'chuk VP
    Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of platinum complexes in athymic mice with human tumors].
    Bukharov IK; Osokina LI; Revazova ES; Moroz LV
    Vopr Onkol; 1988; 34(9):1084-7. PubMed ID: 3188435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [JM216, an orally active platine derivative].
    Lansiaux A; Bailly C
    Bull Cancer; 2000 Jul; 87(7-8):531-6. PubMed ID: 10969209
    [No Abstract]   [Full Text] [Related]  

  • 17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.
    Raynaud FI; Boxall FE; Goddard P; Barnard CF; Murrer BA; Kelland LR
    Anticancer Res; 1996; 16(4A):1857-62. PubMed ID: 8712713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M; Balázová E; Ujházy V
    Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platinum-based antineoplastic agents: biomedical applications and therapeutic aspects].
    Dominici C; Petrucci F; Alimonti A; La Torre F; Cifani A; Caroli S
    Ann Ist Super Sanita; 1995; 31(2):289-94. PubMed ID: 8561393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.